FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149511713> ?p ?o ?g. }

• W2149511713 endingPage "1060" @default.
• W2149511713 startingPage "1053" @default.
• W2149511713 abstract "Plasma oxidized low-density lipoprotein (OX-LDL) levels are elevated in patients with renal diseases, including diabetic nephropathy. We examined effects of OX-LDL on cell proliferation and extracellular matrix (ECM) production by using normal human mesangial cells. Furthermore, we examined possible involvement of peroxisome proliferator-activated receptor gamma (PPARγ). Mesangial cell proliferation with OX-LDL, 9-hydroxy-10,12-octadecadienoic acid (9HODE), and 13-hydroxy-9,11-octadecadienoic acid (13HODE), the major components of OX-LDL, were determined by 5-bromo-2'-deoxyuridine (BrdU) or 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) incorporation. The effect of OX-LDL on mesangial cell proliferation with PD98059 pretreatment was determined by BrdU incorporation. Type IV collagen, fibronectin, and PPARγ expression with OX-LDL or 9HODE or 13HODE was determined by Western blotting. Type IV collagen expression with antisense oligonucleotide against PPARγ pretreatment was also determined by Western blotting. The effect of PD98059 pretreatment on PPARγ expression was determined by Western blotting. In mesangial cells exposed to isolated OX-LDL from human plasma, BrdU incorporation was increased, and this increase was deleted by PD98059. Type IV collagen expression was significantly increased by OX-LDL. 9HODE and 13HODE increased BrdU and MTT incorporation into mesangial cells and also increased expressions of Type IV collagen and fibronection, the major components of ECM. PPARγ expression in mesangial cells was stimulated by 9HODE. The reduction of PPARγ synthesis by pretreatment of antisense oligonucleotide against PPARγ remarkably attenuated Type IV collagen synthesis induced by 9HODE. PPARγ expression induced by 9HODE was also reduced by PD98059 pretreatment. These findings demonstrate that 9HODE, the major component of OX-LDL, stimulates cell proliferation and ECM production of human mesangial cells. In addition, the stimulatory effects are, at least in part, mediated by PPARγ, which may exist in downstream of ERK1/2 pathway." @default.
• W2149511713 created "2016-06-24" @default.
• W2149511713 creator A5000776443 @default.
• W2149511713 creator A5023866057 @default.
• W2149511713 creator A5025278284 @default.
• W2149511713 creator A5031183549 @default.
• W2149511713 creator A5032700393 @default.
• W2149511713 creator A5036207046 @default.
• W2149511713 date "2004-11-01" @default.
• W2149511713 modified "2023-09-24" @default.
• W2149511713 title "9HODE Stimulates Cell Proliferation and Extracellular Matrix Synthesis in Human Mesangial Cells via PPARγ" @default.
• W2149511713 cites W1963713924 @default.
• W2149511713 cites W1966948164 @default.
• W2149511713 cites W1969658990 @default.
• W2149511713 cites W1976621212 @default.
• W2149511713 cites W1981367349 @default.
• W2149511713 cites W1986517102 @default.
• W2149511713 cites W1989811320 @default.
• W2149511713 cites W1990641914 @default.
• W2149511713 cites W1998857876 @default.
• W2149511713 cites W2001047636 @default.
• W2149511713 cites W2002084587 @default.
• W2149511713 cites W2012592975 @default.
• W2149511713 cites W2024183861 @default.
• W2149511713 cites W2027356789 @default.
• W2149511713 cites W2033370073 @default.
• W2149511713 cites W2040187493 @default.
• W2149511713 cites W2044454983 @default.
• W2149511713 cites W2047982128 @default.
• W2149511713 cites W2051159435 @default.
• W2149511713 cites W2055530781 @default.
• W2149511713 cites W2056641203 @default.
• W2149511713 cites W2060746205 @default.
• W2149511713 cites W2061755142 @default.
• W2149511713 cites W2062539665 @default.
• W2149511713 cites W2064536844 @default.
• W2149511713 cites W2080419804 @default.
• W2149511713 cites W2081040987 @default.
• W2149511713 cites W2084610536 @default.
• W2149511713 cites W2087647782 @default.
• W2149511713 cites W2089316009 @default.
• W2149511713 cites W2096929695 @default.
• W2149511713 cites W2117392411 @default.
• W2149511713 cites W2120797568 @default.
• W2149511713 cites W2136976666 @default.
• W2149511713 cites W2148992655 @default.
• W2149511713 cites W2156255102 @default.
• W2149511713 cites W2161165626 @default.
• W2149511713 cites W2171363744 @default.
• W2149511713 cites W2172264949 @default.
• W2149511713 cites W2017526583 @default.
• W2149511713 doi "https://doi.org/10.1177/153537020422901010" @default.
• W2149511713 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15522842" @default.
• W2149511713 hasPublicationYear "2004" @default.
• W2149511713 type Work @default.
• W2149511713 sameAs 2149511713 @default.
• W2149511713 citedByCount "18" @default.
• W2149511713 countsByYear W21495117132012 @default.
• W2149511713 countsByYear W21495117132013 @default.
• W2149511713 countsByYear W21495117132014 @default.
• W2149511713 countsByYear W21495117132015 @default.
• W2149511713 countsByYear W21495117132016 @default.
• W2149511713 countsByYear W21495117132017 @default.
• W2149511713 countsByYear W21495117132019 @default.
• W2149511713 countsByYear W21495117132021 @default.
• W2149511713 crossrefType "journal-article" @default.
• W2149511713 hasAuthorship W2149511713A5000776443 @default.
• W2149511713 hasAuthorship W2149511713A5023866057 @default.
• W2149511713 hasAuthorship W2149511713A5025278284 @default.
• W2149511713 hasAuthorship W2149511713A5031183549 @default.
• W2149511713 hasAuthorship W2149511713A5032700393 @default.
• W2149511713 hasAuthorship W2149511713A5036207046 @default.
• W2149511713 hasConcept C104317684 @default.
• W2149511713 hasConcept C126322002 @default.
• W2149511713 hasConcept C134018914 @default.
• W2149511713 hasConcept C153911025 @default.
• W2149511713 hasConcept C170493617 @default.
• W2149511713 hasConcept C185592680 @default.
• W2149511713 hasConcept C187345961 @default.
• W2149511713 hasConcept C189165786 @default.
• W2149511713 hasConcept C2777107211 @default.
• W2149511713 hasConcept C2779131090 @default.
• W2149511713 hasConcept C2779814568 @default.
• W2149511713 hasConcept C2780091579 @default.
• W2149511713 hasConcept C2780644872 @default.
• W2149511713 hasConcept C55493867 @default.
• W2149511713 hasConcept C62112901 @default.
• W2149511713 hasConcept C71924100 @default.
• W2149511713 hasConcept C85265743 @default.
• W2149511713 hasConcept C86492073 @default.
• W2149511713 hasConcept C86803240 @default.
• W2149511713 hasConceptScore W2149511713C104317684 @default.
• W2149511713 hasConceptScore W2149511713C126322002 @default.
• W2149511713 hasConceptScore W2149511713C134018914 @default.
• W2149511713 hasConceptScore W2149511713C153911025 @default.
• W2149511713 hasConceptScore W2149511713C170493617 @default.
• W2149511713 hasConceptScore W2149511713C185592680 @default.
• W2149511713 hasConceptScore W2149511713C187345961 @default.

• next